These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 30854646)
1. Clinical and molecular characterization of early-onset colorectal cancer. Willauer AN; Liu Y; Pereira AAL; Lam M; Morris JS; Raghav KPS; Morris VK; Menter D; Broaddus R; Meric-Bernstam F; Hayes-Jordan A; Huh W; Overman MJ; Kopetz S; Loree JM Cancer; 2019 Jun; 125(12):2002-2010. PubMed ID: 30854646 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics. Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948 [TBL] [Abstract][Full Text] [Related]
4. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)]. Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988 [TBL] [Abstract][Full Text] [Related]
5. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
6. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer. Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181 [TBL] [Abstract][Full Text] [Related]
7. The increasing incidence of young-onset colorectal cancer: a call to action. Ahnen DJ; Wade SW; Jones WF; Sifri R; Mendoza Silveiras J; Greenamyer J; Guiffre S; Axilbund J; Spiegel A; You YN Mayo Clin Proc; 2014 Feb; 89(2):216-24. PubMed ID: 24393412 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. Overman MJ; Adam L; Raghav K; Wang J; Kee B; Fogelman D; Eng C; Vilar E; Shroff R; Dasari A; Wolff R; Morris J; Karunasena E; Pisanic TR; Azad N; Kopetz S Ann Oncol; 2018 Jan; 29(1):139-144. PubMed ID: 29069279 [TBL] [Abstract][Full Text] [Related]
9. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812 [TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular features of young-onset colorectal cancer. Ballester V; Rashtak S; Boardman L World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533 [TBL] [Abstract][Full Text] [Related]
11. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S; JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041 [TBL] [Abstract][Full Text] [Related]
12. Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration. Sekal M; Ameurtesse H; Chbani L; Ouldim K; Bennis S; Abkari M; Boulouz A; Benajah DA; Benjelloun B; Ousadden A; Ait Taleb K; Ait Laalim S; Toghrai I; Mazaz K; Arifi S; Mellas N; El Rhazi K; Harmouch T; Ibrahimi SA; Amarti Riffi A Diagn Pathol; 2015 Jun; 10():77. PubMed ID: 26104511 [TBL] [Abstract][Full Text] [Related]
13. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1. Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226 [TBL] [Abstract][Full Text] [Related]
14. Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis. Chen FW; Sundaram V; Chew TA; Ladabaum U Clin Gastroenterol Hepatol; 2017 May; 15(5):728-737.e3. PubMed ID: 27856366 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Characteristics and Outcome of Adolescent and Young Adult-Onset Microsatellite Stable Colorectal Cancer Patients. Sukhokanjanachusak K; Pongpaibul A; Nimmannit A; Akewanlop C; Korphaisarn K J Adolesc Young Adult Oncol; 2021 Oct; 10(5):573-580. PubMed ID: 33085547 [No Abstract] [Full Text] [Related]
17. Age at onset should be a major criterion for subclassification of colorectal cancer. Perea J; Rueda D; Canal A; Rodríguez Y; Álvaro E; Osorio I; Alegre C; Rivera B; Martínez J; Benítez J; Urioste M J Mol Diagn; 2014 Jan; 16(1):116-26. PubMed ID: 24184227 [TBL] [Abstract][Full Text] [Related]
18. Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study. Haasnoot KJC; Backes Y; Moons LMG; Kranenburg O; Trinh A; Vermeulen L; Noë M; Tuynman JB; van Lent AUG; van Ginneken R; Seldenrijk CA; Raicu MG; Trumpi K; Ubink I; Milne AN; Boonstra JJ; Groen JN; Schwartz MP; Wolfhagen FHJ; Geesing JMJ; Ter Borg F; Brosens LAA; van Bergeijk J; Spanier BWM; de Vos Tot Nederveen Cappel WH; Kessels K; Seerden TCJ; Vleggaar FP; Offerhaus GJA; Siersema PD; Elias SG; Laclé MM; Mod Pathol; 2020 Dec; 33(12):2626-2636. PubMed ID: 32581367 [TBL] [Abstract][Full Text] [Related]
19. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States. Montminy EM; Zhou M; Maniscalco L; Abualkhair W; Kim MK; Siegel RL; Wu XC; Itzkowitz SH; Karlitz JJ Ann Intern Med; 2021 Feb; 174(2):157-166. PubMed ID: 33315473 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]